首页> 中文期刊> 《中外医学研究》 >拉米夫定治疗慢性乙肝患者耐药后的健康教育调查分析

拉米夫定治疗慢性乙肝患者耐药后的健康教育调查分析

         

摘要

目的:了解慢性乙肝患者发生拉米夫定(Lamivudine,LAM)耐药后对健康教育内容及其方式的需求,为慢性乙肝患者提高治疗的依从性和促进预后提供指导。方法:横断面调查152例LAM单药抗病毒治疗耐药后的慢性乙肝患者,分析其对健康教育内容及方式的需求。结果:患者对健康教育内容的需求较多,其中耐药后续治疗及预后需求所占比例最高,均达100%。其次是再次用抗病毒药疗程、治疗费用、更换其他抗病毒药的不良反应所占比例较高,依次为89.47%、85.53%、81.58%。同时,孩子对健康教育方式的需求中希望与专科医务人员交流进行健康教育的人最多,达100%。其次选择固定时间向肝病专家咨询和专家健康讲座的患者所占比例较高,分别为90.79%和88.16%。结论:医务人员就慢性乙肝患者发生LAM耐药后对健康教育内容及其方式的需求,有针对的提供指导,可以提高患者对治疗的依从性,促进预后。%Objective:To analyze the contents and forms of the health education demanded by chronic hepatitis B patients with lamivudine-resistant, to provide suggestion to improve their treatment compliance and prognosis.Method:152 cases of chronic hepatitis B patients with lamivudine-resistant were investigated using questionnaire and their needs for health education were analyzed.Result:The patients had more health education content demands,most needed were knowledge about successive treatment and prognosis after lamivudine-resistant,the rate of both were 100%.Followed needs were knowledge about schedule and cost of antiviral treatment,the side effects of substituted drugs,the rates were 89.47%,85.53%,81.58%respectively.As to forms of health education, 100%of the investigators hope to get needed information by communicating with health workers directly.Others forms including regularly consulting with liver specialists and attending health education lecture delivered by liver specialists,the rates were 90.79%,88.16% respectively.Conclusion:Pertinent health education based on the needs of hepatitis B patients with lamivudine-resistant should be provided by health workers to promote their treatment compliance and prognosis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号